Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

NCT00088049 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00088049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00088049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2003
Completion date
July 31, 2007
Enrollment
560
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia